Abstract: (24 Views)
This review explores advancements in the food industry for developing functional foods to manage diabetes. It evaluates the mechanisms and clinical evidence for eight bioactive components. Dietary fibers help control blood sugar levels and insulin sensitivity by slowing glucose absorption and promoting the production of short-chain fatty acids. Polyphenols reduce glucose spikes by inhibiting carbohydrate-digesting enzymes and activating signaling pathways like AMPK. Antioxidants protect pancreatic β-cells and insulin secretion by combating oxidative stress and inflammation. Probiotics and prebiotics improve metabolic balance by modulating gut microbiota and strengthening the intestinal barrier. Omega-3 and monounsaturated fatty acids reduce inflammation and enhance insulin receptor signaling. Fermented foods provide bioactive compounds with hypoglycemic effects, while alkaloids, flavonoids, and terpenoids have diverse anti-diabetic properties. Clinical trials have shown promising results in lowering fasting glucose, HbA1c and postprandial spikes, but limitations like small sample sizes and inconsistent formulations call for further validation through robust randomized controlled trials. Conflicting results across studies emphasize the need for cautious interpretation.
Type of Study:
Research |
Subject:
Special Received: 2025/10/26 | Accepted: 2025/12/23 | Published: 2025/12/23